HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noble, A. Articles by Cantor, H. Search for Related Content PubMed PubMed Citation Articles by Noble, A. Articles by Cantor, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH

Suppression of Immune Responses by CD8 Cells. I. Superantigen-Activated CD8 Cells Induce Unidirectional Fas-Mediated Apoptosis of Antigen-Activated CD4 Cells¹

Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115

Stimulation of mature CD4 cells through the TCR induces cellular activation and expansion that are often followed by clonal elimination by a form of apoptosis³ termed activation-induced cell death. This process of CD4 cell apoptosis is generally thought to reflect clonal suicide and to be independent of other cell types. Here we show that during the response to the superantigen Staphylococcal enterotoxin A, activated CD8 cells, but not activated CD4 cells, suppress the CD4 proliferative response. Suppression by CD8 cells reflects their ability to induce CD4 cell apoptosis via ligation of Fas. Moreover, although activated CD8 cells that express Fas ligand and Fas eliminate CD4 cells through a Fas-dependent mechanism, they are themselves resistant to Fas-dependent apoptosis. These findings indicate a fundamental difference between the two major T cell subsets with regard to sensitivity to Fas-dependent apoptosis, expression of Fas ligand, and mediation of suppressive activity following immunization with superantigen.

This article has been cited by other articles:

				Y. Fang, G. C. Sharp, and H. Braley-Mullen Interleukin-10 Promotes Resolution of Granulomatous Experimental Autoimmune Thyroiditis Am. J. Pathol., June 1, 2008; 172(6): 1591 - 1602. [Abstract] [Full Text] [PDF]

				M. M. Kosiewicz, P. Alard, S. Liang, and S. L Clark Mechanisms of tolerance induced by transforming growth factor-{beta}-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand Int. Immunol., May 1, 2004; 16(5): 697 - 706. [Abstract] [Full Text] [PDF]

				B. Adams, N. Nagy, F. Paulart, M.-L. Vanderhaeghen, M. Goldman, and V. Flamand CD8+ T Lymphocytes Regulating Th2 Pathology Escape Neonatal Tolerization J. Immunol., November 15, 2003; 171(10): 5071 - 5076. [Abstract] [Full Text] [PDF]

				M. Guadalupe, E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy J. Virol., November 1, 2003; 77(21): 11708 - 11717. [Abstract] [Full Text] [PDF]

				L. Myers, C. Takahashi, R. S. Mittler, R. J. Rossi, and A. T. Vella Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering PNAS, April 29, 2003; 100(9): 5348 - 5353. [Abstract] [Full Text] [PDF]

				S.-U. Lee, W. Ferens, W. C. Davis, M. J. Hamilton, Y.-H. Park, L. K. Fox, J. Naessens, and G. A. Bohach Identity of Activation Molecule 3 on Superantigen-Stimulated Bovine Cells Is CD26 Infect. Immun., November 1, 2001; 69(11): 7190 - 7193. [Abstract] [Full Text] [PDF]

				H. Tang, K. Chen, Y. Wei, G. C. Sharp, L. McKee, and H. Braley-Mullen Apoptosis of thyrocytes and effector cells during induction and resolution of granulomatous experimental autoimmune thyroiditis Int. Immunol., December 1, 2000; 12(12): 1629 - 1639. [Abstract] [Full Text] [PDF]

				M. Jenkins, M. Keir, and J. M. McCune A Membrane-bound Fas Decoy Receptor Expressed by Human Thymocytes J. Biol. Chem., March 10, 2000; 275(11): 7988 - 7993. [Abstract] [Full Text] [PDF]

				H. Suzuki, Y. W. Zhou, M. Kato, T. W. Mak, and I. Nakashima Normal Regulatory {alpha}/{beta} T Cells Effectively Eliminate Abnormally Activated T Cells Lacking the Interleukin 2 Receptor {beta} In Vivo J. Exp. Med., December 6, 1999; 190(11): 1561 - 1572. [Abstract] [Full Text] [PDF]

				D. M. KEMENY, B. VYAS, M. VUKMANOVIC-STEJIC, M. J. THOMAS, A. NOBLE, L.-C. LOH, and B. J. O'CONNOR CD8+ T Cell Subsets and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S33 - 37. [Abstract] [Full Text] [PDF]

				M. Jenkins, M. Keir, and J. M. McCune Fas Is Expressed Early in Human Thymocyte Development But Does Not Transmit an Apoptotic Signal J. Immunol., August 1, 1999; 163(3): 1195 - 1204. [Abstract] [Full Text] [PDF]

				W. Stohl, D. H. Lynch, G. C. Starling, and P. A. Kiener Superantigen-Driven, CD8+ T Cell-Mediated Down-Regulation: CD95 (Fas)-Dependent Down-Regulation of Human Ig Responses Despite CD95-Independent Killing of Activated B Cells J. Immunol., October 1, 1998; 161(7): 3292 - 3298. [Abstract] [Full Text] [PDF]